- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Standard Chemical & Pharmaceutical Co Ltd (1720)
Assess today's live Standard Chemical & Pharmaceutical Co Ltd (1720) share price, performance and insights using our live Taiwan: 1720 stock exchange data.
Analyse the historical data and Standard Chemical & Pharmaceutical Co Ltd share price performance charts on this page. Our technical summary section provides analysis on SCPC share price buy/sell indicators using real-time data (or discuss the SCPC (1720) stock price today with other investors in the SCPC TW share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current TW 1720 share price (ISIN: TW0001720001) to enhance your trading decisions with our free investment tools and resources.
What Is the Standard Chemical & Pharmaceutical Co Ltd Share Price Today?
The SCPC share price today is 60.70.
What Is the Stock Symbol for Standard Chemical & Pharmaceutical Co Ltd
The stock symbol (or 'ticker') for Standard Chemical & Pharmaceutical Co Ltd is "1720."
What Stock Exchange Does Standard Chemical & Pharmaceutical Co Ltd Trade On?
Standard Chemical & Pharmaceutical Co Ltd is listed and trades on the Taiwan stock exchange.
Is Standard Chemical & Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Standard Chemical & Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Standard Chemical & Pharmaceutical Co Ltd share price performance charts on this page. Our technical summary section provides analysis on SCPC share price buy/sell indicators using real-time data (or discuss the SCPC (1720) stock price today with other investors in the SCPC TW share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current TW 1720 share price (ISIN: TW0001720001) to enhance your trading decisions with our free investment tools and resources.
What Is the Standard Chemical & Pharmaceutical Co Ltd Share Price Today?
The SCPC share price today is 60.70.
What Is the Stock Symbol for Standard Chemical & Pharmaceutical Co Ltd
The stock symbol (or 'ticker') for Standard Chemical & Pharmaceutical Co Ltd is "1720."
What Stock Exchange Does Standard Chemical & Pharmaceutical Co Ltd Trade On?
Standard Chemical & Pharmaceutical Co Ltd is listed and trades on the Taiwan stock exchange.
Is Standard Chemical & Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Standard Chemical & Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Taiwan
Currency in TWD
60.70
-0.30(-0.49%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
60.50
61.40
52 wk Range
53.50
66.60
Earnings results expected in 6 days
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
60.5061.40
52 wk Range
53.5066.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.66%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.66%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1720 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
73.00
Upside
+20.26%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 73.00
(+20.26% Upside)
Earnings
Latest Release
25/02/2026
EPS / Forecast
1.27 / 1.37
Revenue / Forecast
1.79B / 1.85B
Compare 1720 to Peers and Sector
Metrics to compare | 1720 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1720PeersSector | |
|---|---|---|---|---|
P/E Ratio | 11.7x | 21.7x | −0.5x | |
PEG Ratio | 2.21 | −1.12 | 0.00 | |
Price/Book | 1.8x | 1.7x | 2.6x | |
Price / LTM Sales | 1.5x | 1.4x | 3.2x | |
Upside (Analyst Target) | - | 43.6% | 47.8% | |
Fair Value Upside | Unlock | 23.4% | 5.9% | Unlock |
Standard Chemical & Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese and western medicines, cosmetics, beverages, general instruments, and medical devices. It also provides western pharmaceuticals for cardiovascular, metabolic, genitourinary and sex steroids, respiratory, musculoskeletal, digestive, nervous, and circulatory systems; anti-infectives and topical medications; and cancer and cancer antiemetic. In addition, the company offers health food products. Further, it is involved in the manufacture and sale of active pharmaceutical ingredients, as well as veterinary drugs; and sales of medical devices and infant milk powder. It also exports its products. The company was incorporated in 1967 and is headquartered in Tainan City, Taiwan.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the SCPC (Taiwan: 1720) Share Price Today?
The SCPC stock price today is 60.70 TWD.
What Stock Exchange Does SCPC (1720) Trade On?
SCPC is listed and trades on the Taiwan Stock Exchange.
What Is the Ticker (Stock Symbol) for SCPC?
The stock symbol (also called a 'ticker') for SCPC is "1720."
Does SCPC Pay Dividends? What’s The Current 1720 Dividend Yield?
Yes, 1720 Pays Dividends to its Shareholders. The current SCPC dividend yield is 4.66%.
What Is the Current SCPC Market Capitalisation?
As of today, SCPC (Taiwan: 1720) market cap is 10.85B TWD.
What Is SCPC's (1720) Earnings Per Share (TTM)?
The SCPC EPS is currently 5.18 (Trailing Twelve Months).
When Is the Next SCPC Earnings Date?
SCPC's next earnings report will be released on 12/05/2026.
Is 1720 a Buy or Sell From a Technical Analyst Perspective?
Based on today's SCPC moving averages and other technical indicators, the daily buy/sell signal for 1720 stock is Strong Sell.
How Many Times Has SCPC Stock Split?
SCPC has split 9 times. (See the 1720 stock split history page for full effective split date and price information.)
What is the current trading status of SCPC (Taiwan: 1720)?
As of 06/05/2026, SCPC (1720) is trading at a share price of 60.70 TWD, with a previous close of 60.10 TWD. The stock has fluctuated within a day range of 60.50 TWD to 61.40 TWD, while its 52-week range spans from 53.50 TWD to 66.60 TWD.
What Is SCPC (1720) Price Target According to Analysts?
The average 12-month price target for SCPC is 73.00 TWD, with a high estimate of 73 TWD and a low estimate of 73 TWD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +20.26% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.